M-A | Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. 9 Dec, 2022 | 13:20h | UTC Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis – Heart